calendar
4 catalysts · 44 phase 2 completion · 33 phase 1 completion · 24 phase 1 2 completion · 21 phase 2 initiation · 17 phase 1 initiation · 13 phase 1 2 initiation
next 91 dayslessmore
MonWedFri
4 catalysts · 44 phase 2 completion · 33 phase 1 completion · 24 phase 1 2 completion · 21 phase 2 initiation · 17 phase 1 initiation · 13 phase 1 2 initiation
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Myelodysplastic Syndrome (Preleukemia)
Therapy area: Oncology. Indication: Diffuse Large B-Cell Lymphoma, Primary Mediastinal B-Cell Lymphoma
Therapy area: Cardiovascular, Gastrointestinal. Indication: Endothelial Dysfunction, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
Therapy area: Oncology. Indication: Hormone-Sensitive Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Prostate Cancer, Prostate Cancer